eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
. the software can help physicians administer emergency treatment more quickly and also predict the one's chances of developing dementia.
.
.
our partners
.
.
when hard rains fall, the media are there with an umbrella to hold over organized society�s head. to walk away in the middle of a downpour would leave the status quo unprotected.
.
.